Nitric Acid

Nitric Acid

SCHEMBL27720595

COc1ccc(NC(C)=O)cc1.O=[N+]([O-])O

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ERG11

The experimentally established mechanism targets of Nitric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.60
NPC1 O15118 3/20 0.59
RAB9A P51151 3/20 0.59
SMN1; SMN2 Q16637 3/20 0.59
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
MAPT P10636 5/20 0.57
ALDH1A1 P00352 4/20 0.57
HTT P42858 1/20 0.57
HSD17B10 Q99714 1/20 0.57
MTNR1A P48039 1/20 0.56
MTNR1B P49286 1/20 0.56
ALOX5 P09917 1/20 0.56
TP53 P04637 1/20 0.54
ALOX15 P16050 1/20 0.54
POLB P06746 2/20 0.54
LMNA P02545 2/20 0.54
HSP90AA1 P07900 1/20 0.54
CYP1A2 P05177 1/20 0.53
TDP1 Q9NUW8 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL171415 0.89 SMN1; SMN2 (0.73) IDO1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL14384396 0.84 MTNR1A (0.76) IDO1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL9571811 0.84 MTNR1A (0.71) IDO1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL13728829 0.81 IDO1 (0.71) IDO1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL6814406 0.81 CYP1A2 (0.69) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL3468387 0.81 MAPT (0.68) IDO1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL11481934 0.81 IDO1 (0.66) IDO1NPC1RAB9ASMN1; SMN2MEN1
Nitric Acid SCHEMBL5354098 0.80 ALDH1A1 (0.52) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL10923463 0.80 IDO1 (0.57) IDO1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL18409069 0.79 NPC1 (0.67) IDO1NPC1RAB9ASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101309917-B Stomach H with enhanced therapeutic properties+,K+-deuteration inhibitors of ATPase AUSPEX PHARMACEUTICALS INC 2013-09-11 CN disclosed
CN-101309917-A Stomach H with enhanced therapeutic properties+,K+-deuteration inhibitors of ATPase AUSPEX PHARMACEUTICALS INC (US) 2008-11-19 CN disclosed